|Robert S. White|
President and CEO
Robert S. White joined us as President and Chief Operating Officer in November 2014 and was appointed Chief Executive Officer and a member of the Board of Directors in April 2015. Previously, Mr. White was the President and Chief Executive Officer of TYRX, Inc., which specialized in commercializing innovative, implantable combination drug and device products focused on infection control, from January 2010 to March 2014, when TYRX was sold to Medtronic. Prior to joining TYRX, Mr. White held several positions with Medtronic from February 2003 to November 2009, including serving as President of Medtronic Kyphon from April 2008 to August 2009 following the acquisition of Kyphon by Medtronic. Mr. White started his career with General Electric and joined Eli Lilly and Company in 1989. Mr. White serves on the Boards of Directors of several companies, including publicly traded companies Novadaq Technologies (September 2014 to present) and AtriCure, Inc. (March 2013 to present), as well as HyperBranch Medical Technology, Inc. (June 2010 to present). Mr. White holds a B.S. in Aerospace Engineering from the University of Missouri-Rolla and an M.B.A. from Cornell University’s Johnson Graduate School of Management.
|Brent A. Moen|
Brent Moen has served as our Chief Financial Officer since May 23, 2016. Prior to joining Entellus, Mr. Moen served as Executive Vice President and Chief Financial Officer of ABRA Auto Body & Glass LP, an auto body and glass company, from November 2013 to May 2015. Prior to joining ABRA, Mr. Moen served as Senior Vice President and Chief Financial Officer of Regis Corporation, a publicly held owner, franchisor and operator of beauty salons, from January 2011 to December 2012. Prior to that position, from 2000 to January 2011, Mr. Moen held various financial roles of increasing responsibility with Regis Corporation. Mr. Moen holds a B.A. in Accounting from the University of North Dakota.
|Michael H. Rosenthal|
Chief Operating Officer
Mike Rosenthal has served as our Chief Operating Officer since November 2017 and from July 2017 to October 2017 served as our General Manager. From May 2015 to July 2017, Mr. Rosenthal served as Chief Strategic and Technology Officer of Spirox, Inc., a medical device company acquired by Entellus in July 2017. From December 2012 to May 2015, Mr. Rosenthal served as General Partner of D3DC, LLC, a medical device management company. Mr. Rosenthal holds a B.S. in Mechanical Engineering from Stanford University.
|Donald Gonzales, M.D.|
Chief Medical Officer
Donald Gonzales, M.D. has served as our Chief Medical Officer since July 13, 2017. From May 2015 to July 2017, Dr. Gonzales served as Chief Medical Officer of Spirox, Inc., a medical device company acquired by Entellus in July 2017. From December 2012 through May 2015, Dr. Gonzales was self-employed as a General Partner for D3DC, LLC, a medical device management company. From March 2007 to April 2011, Dr. Gonzales served as Chief Medical Officer of Entrigue Surgical, Inc., a medical device company, and from May 2011 to April 2012, he served as a consultant for Entrigue Surgical, Inc. Dr. Gonzales holds a Doctorate in Medicine from Cornell University.
|Thomas P. Williamson|
Vice President, Commercial Operations
Thomas P. Williamson has served as our Vice President, Commercial Operations since November 2017 and from January 2017 to October 2017 served as our Vice President of Sales. Mr. Williamson joined Entellus in December 2011 as Regional Vice President of Sales. Prior to joining Entellus, Mr. Williamson held several positions with Stryker Corporation from March 2003 to July 2011, including serving as the National Sales Director for the Interventional Spine Division. Prior to Stryker, Mr. Williamson held roles at both Parametric Technology Corporation and Nalco Chemical Company. Mr. Williamson holds a B.S. in Chemical Engineering from Louisiana State University.